Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic, diplomats at the World Health Organization said on Saturday.
In a statement to Reuters, the International Federation of Pharmaceutical Manufacturers and Associations, which represents 26 research-based drugmakers, welcomed the plan and confirmed the commitments its members had undertaken as part of it.
Negotiators ended an all-night session with a draft agreement accepted by all countries, including the United States, the last to join the consensus, diplomats said.
"The negotiations are finished. The framework was agreed," an aide to Mexico's ambassador Juan Jose Gomez Camacho, co-chairman of the closed-door talks, told Reuters.
Health ministers were expected to adopt the framework deal, which lays down participation by the drug industry, at the WHO's annual meeting being held May 16-24.
Countries would share virus samples with the WHO's network of laboratories in return for affordable vaccines derived from them. The industry has pledged to donate drugs and know-how, covering half of the $58 million annual cost of boosting defenses in the poorest nations, according to senior envoys.
Negotiations began four years ago among the WHO's 193 members after the deadly H5N1 bird flu virus emerged in southeast Asia. A year later, Indonesia stopped sharing flu virus samples with the WHO, demanding its share of vaccines.
Indonesia joined in the consensus reached, diplomats said.
The IFPMA, whose Big Pharma members span Europe, Japan and the United States, said it was studying the plan that would need "fine-tuning" in the coming year.
GlaxoSmithKline, Novartis and Sanofi-Aventis, are among major flu vaccine makers, and along with Tamiflu-maker Roche, are IFPMA members.
But negotiators appeared to have "reached a decision that will result in an effective global system to prepare for potential future influenza pandemics, recognizing a shared responsibility to help secure the world against future pandemic influenza outbreaks," the Geneva-based IFPMA said in a statement sent to Reuters by an authorized industry source.
In talks with negotiators, its members had pledged to "reserve at least 10 percent of pandemic vaccine manufacturing capacity on a real-time basis, for donation to the WHO and/or supply at tiered prices, to developing countries," it said.
They would also reserve at least 10 percent of antiviral manufacturing capacity for donation on the same basis.
"It is crucial that the system allow for rapid access to pandemic viruses and for benefits to be allocated to those countries most in need," the IFPMA said.
"IFPMA members will continue to ensure that intellectual property rights do not present a barrier at the next pandemic."
During the H1N1 swine flu pandemic in 2009-2010, many developing countries complained they had no life-saving antivirals or vaccines to combat the new virus.
The WHO helped distribute 78 million vaccines, donated by rich nations and drugmakers, to 77 developing countries, but regulatory and other hurdles slowed the process.
The pharmaceutical industry has pledged to step up its role.
"Industry agreed what its role will be. They will be able to choose between donations and intellectual property," a diplomatic source told Reuters early on Saturday.
This meant drug companies could donate significant amounts of vaccines or antivirals, or transfer technology, he said.
Drug companies say current production capacity for pandemic flu vaccine is 1.1 billion doses.
(Editing by Sophie Hares)
Copyright 2011 Thomson Reuters. Click for Restrictions.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.